home

Mission Statement

The mission of the Psychiatric Cell Map Initiative (PCMI) is to bridge the gap between the genome and clinic in the field of neuropsychiatric disorder research by systematically mapping the physical and genetic interaction networks underlying these disorders, including autism spectrum disorders, Tourette disorder, epilepsy, intellectual disability, and schizophrenia. This will form a key resource ...

Read More

The mission of the Psychiatric Cell Map Initiative (PCMI) is to bridge the gap between the genome and clinic in the field of neuropsychiatric disorder research by systematically mapping the physical and genetic interaction networks underlying these disorders, including autism spectrum disorders, Tourette disorder, epilepsy, intellectual disability, and schizophrenia. This will form a key resource for precision medicine.

What is PCMI?

PCMI is an interdisciplinary collaborative research effort to study cell mapping of neuropsychiatric disorders.

October

16

2018 Funding Academic Neurotherapeutic Discovery with Charles Cywin

Read More

October

23-24

NCRCRG/CN 2019 Consortium Meeting

Read More

November

13-15

PCMI 2019 Psychiatric Cell Map Symposium

Read More